Trials / Completed
CompletedNCT02175017
ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer
ONO-4538 Multicenter, Open-label, Uncontrolled, Phase II Study in Advanced Non-small Cell Lung Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to investigate the efficacy and safety of ONO-4538 in subjects with stage IIIB/IV or recurrent non-small cell lung cancer unsuited to radical radiotherapy and resistant to a platinum-based chemotherapeutic regimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-4538 | ONO-4538 Study in Patients With Squamous NSCLC |
| DRUG | ONO-4538 | ONO-4538 Study in Patients With Non-Squamous NSCLC |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-11-01
- Completion
- 2021-02-01
- First posted
- 2014-06-26
- Last updated
- 2024-12-09
- Results posted
- 2024-12-09
Locations
10 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02175017. Inclusion in this directory is not an endorsement.